Microstructure and Mechanical Properties of Inverse Nanocomposite Made from Polylactide and Hydroxyapatite Nanoparticles

Three-Dimensional-Printed Molds from Water-Soluble Sulfate Ceramics for Biocomposite Formation through Low-Pressure Injection Molding

Powder mixtures of MgSO₄ with 5-20 mol.% Na₂SO₄ or K₂SO₄ were used as precursors for making water-soluble ceramic molds to create thermoplastic polymer/calcium phosphate composites by low pressure injection molding. To increase the strength of the ceramic molds, 5 wt.% of tetragonal ZrO₂ (Y₂O₃-stabilized) was added to the precursor powders. A uniform distribution of ZrO₂ particles was obtained. The average grain size for Na-containing ceramics ranged from 3.5 ± 0.8 µm for MgSO₄/Na₂SO₄ = 91/9% to 4.8 ± 1.1 µm for MgSO₄/Na₂SO₄ = 83/17%. For K-containing ceramics, the values were 3.5 ± 0.8 µm for all of the samples. The addition of ZrO₂ made a significant contribution to the strength of ceramics: for the MgSO₄/Na₂SO₄ = 83/17% sample, the compressive strength increased by 49% (up to 6.7 ± 1.3 MPa), and for the stronger MgSO₄/K₂SO₄ = 83/17% by 39% (up to 8.4 ± 0.6 MPa). The average dissolution time of the ceramic molds in water did not exceed 25 min.

Airbrushed Polysulfone (PSF)/Hydroxyapatite (HA) Nanocomposites: Effect of the Presence of Nanoparticles on Mechanical Behavior

Nanocomposite films of polysulfone (PSF)—hydroxyapatite (HA) were prepared with a commercial airbrush. Structural, thermal, and mechanical characterization allows obtaining new information to understand the role of the nanofiller–polymer matrix interphase in the final performance of these materials in relation to its possible applications in the restoration of bones. Fourier-transform infrared spectroscopy shows that there are hardly any structural changes in the polymer when adding HA particles. From thermal analysis (differential scanning calorimetry and thermogravimetry), it can be highlighted that the presence of HA does not significantly affect the glass transition temperature of the PSF but decelerates its thermal degradation. All this information points out that any change in the PSF performance because of the addition of HA particles cannot be due to specific interactions between the filler and the polymer. Results obtained from uniaxial tensile tests indicate that the addition of small amounts of HA particles (1% wt) leads to elastic moduli higher than the upper bound predicted by the rule of mixtures suggesting there must be a high contribution of the interphase. A simple model of the nanocomposite is proposed for which three contributions must be considered, particles, interphase and matrix, in such a way that interphases arising from different particles can interact by combining with each other thus leading to a decrease in its global contribution when the amount of particles is high enough. The mechanical behavior can be explained considering a balance between the contribution of the interphase and the number of particles. Finally, a particular mechanism is proposed to explain why in certain nanocomposites relatively high concentrations of nanoparticles may substantially increase the strain to failure.

Biomimetic Citrate-Coated Luminescent Apatite Nanoplatforms for Diclofenac Delivery in Inflammatory Environments

Luminescent nanoparticles are innovative tools for medicine, allowing the imaging of cells and tissues, and, at the same time, carrying and releasing different types of molecules. We explored and compared the loading/release ability of diclofenac (COX-2 antagonist), in both undoped- and luminescent Terbium³⁺ (Tb³⁺)-doped citrate-coated carbonated apatite nanoparticles at different temperatures (25, 37, 40 °C) and pHs (7.4, 5.2). The cytocompatibility was evaluated on two osteosarcoma cell lines and primary human osteoblasts. Biological effects of diclofenac-loaded-nanoparticles were monitored in an in vitro osteoblast’s cytokine–induced inflammation model by evaluating COX-2 mRNA expression and production of PGE₂. Adsorption isotherms fitted the multilayer Langmuir-Freundlich model. The maximum adsorbed amounts at 37 °C were higher than at 25 °C, and particularly when using the Tb³⁺ -doped particles. Diclofenac-release efficiencies were higher at pH 5.2, a condition simulating a local inflammation. The luminescence properties of diclofenac-loaded Tb³⁺ -doped particles were affected by pH, being the relative luminescence intensity higher at pH 5.2 and the luminescence lifetime higher at pH 7.4, but not influenced either by the temperature or by the diclofenac-loaded amount. Both undoped and Tb³⁺-doped nanoparticles were cytocompatible. In addition, diclofenac release increased COX-2 mRNA expression and decreased PGE₂ production in an in vitro inflammation model. These findings evidence the potential of these nanoparticles for osteo-localized delivery of anti-inflammatory drugs and the possibility to localize the inflammation, characterized by a decrease in pH, by changes in luminescence.